Safety and Immunogenicity of Full-Dose Trivalent Inactivated Influenza Vaccine (TIV) Compared With Half-Dose TIV Administered to Children 6 Through 35 Months of Age. (Q36009663)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Safety and Immunogenicity of Full-Dose Trivalent Inactivated Influenza Vaccine (TIV) Compared With Half-Dose TIV Administered to Children 6 Through 35 Months of Age.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Safety and Immunogenicity of Full-Dose Trivalent Inactivated Influenza Vaccine (TIV) Compared With Half-Dose TIV Administered to Children 6 Through 35 Months of Age. (English)

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

influenza vaccine

1 reference

based on heuristic

inferred from title

Patricia L Winokur

object named as

Patricia Winokur

5

0 references

Kathryn M. Edwards

11

object named as

Kathryn M Edwards

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Harry L Keyserling

6

object named as

Harry Keyserling

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Natasha B. Halasa

1

object named as

Natasha B Halasa

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

8

object named as

Heather Hill

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

David I Bernstein

12

object named as

David I Bernstein

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

author name string

Michael A Gerber

2

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Andrea A Berry

3

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Edwin L Anderson

4

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Allison Ross Eckard

7

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Mark C Wolff

9

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Monica M McNeal

10

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

publication date

27 June 2014

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Journal of the Pediatric Infectious Diseases Society

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

4

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

214-224

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

The immunogenicity and safety of a single 0.5 mL dose of virosomal subunit influenza vaccine administered to unprimed children aged ≥6 to <36 months: data from a randomized, Phase III study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4554205

2 October 2017

Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4554205

2 October 2017

Vaccine effectiveness for laboratory-confirmed influenza in children 6-59 months of age, 2005-2007.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4554205

2 October 2017

A systematic review of the evidence on the effectiveness and risks of inactivated influenza vaccines in different target groups

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4554205

2 October 2017

Effectiveness and safety of influenza vaccination in children: European perspective

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4554205

2 October 2017

Randomized controlled trial of dose response to influenza vaccine in children aged 6 to 23 months

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4554205

2 October 2017

Age-specific effectiveness of an oil-in-water adjuvanted pandemic (H1N1) 2009 vaccine against confirmed infection in high risk groups in England

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4554205

2 October 2017

Effectiveness of inactivated influenza vaccine in children aged 9 months to 3 years: an observational cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4554205

2 October 2017

Prevention of influenza: recommendations for influenza immunization of children, 2007-2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4554205

2 October 2017

Safety and efficacy of trivalent inactivated influenza vaccine in young children: a summary for the new era of routine vaccination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4554205

2 October 2017

Inactivated influenza virus vaccines in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4554205

2 October 2017

Mortality associated with influenza and respiratory syncytial virus in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4554205

2 October 2017

Technical report: Reduction of the influenza burden in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4554205

2 October 2017

Studies on reactogenicity and immunogenicity of attenuated bivalent cold recombinant influenza type A (CRA) and inactivated trivalent influenza virus (TI) vaccines in infants and young children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4554205

2 October 2017

Clinical reactions and serologic responses after vaccination with whole-virus or split-virus influenza vaccines in children aged 6 to 36 months

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4554205

2 October 2017

Clinical reactions and serologic response following inactivated monovalent influenza type B vaccine in young children and infants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4554205

2 October 2017

Trials of Influenza A/New Jersey/76 Virus Vaccine in Normal Children: An Overview of Age-Related Antigenicity and Reactogenicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4554205

2 October 2017

Clinical Reactions and Serologic Responses in Healthy Children Aged Six to 35 Months after Two-Dose Regimens of Inactivated A/New Jersey/76 Influenza Virus Vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4554205

2 October 2017

Inactivated influenza A/New Jersey/76 vaccines in children: results of a mult-center trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4554205

2 October 2017

Immune response to split-product influenza vaccine in preterm and full-term young children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4554205

11 July 2018

From the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, the Center for Disease Control, and the Bureau of Biologics of the Food and Drug Administration. Summary of clinical trials of influenza vaccines--I

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4554205

11 July 2018

Reactogenicity and Immunogenicity of Bivalent Influenza Vaccine in One- and Two-Dose Trials in Children: A Summary

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4554205

11 July 2018

WHO Expert Committee on biological standardization.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4554205

23 September 2018

MF59-adjuvanted influenza vaccine (FLUAD) in children: safety and immunogenicity following a second year seasonal vaccination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4554205

23 September 2018

Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4554205

23 September 2018

Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4554205

23 September 2018

Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4554205

23 September 2018

The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4554205

23 September 2018

A randomized clinical trial assessing immunogenicity and safety of a double dose of virosomal-adjuvanted influenza vaccine administered to unprimed children aged 6–35 months

1 reference

https://api.crossref.org/works/10.1093%2FJPIDS%2FPIU061

21 January 2018

Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/26334249

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970-78

1 reference

https://pubmed.ncbi.nlm.nih.gov/26334249

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunization of high-risk infants younger than 18 months of age with split-product influenza vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/26334249

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/26334249

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oil-in-water emulsion adjuvant with influenza vaccine in young children

1 reference

https://pubmed.ncbi.nlm.nih.gov/26334249

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/JPIDS/PIU061

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36009663&oldid=2146975710"